Dear Sir/Madam, Please find the attached statement of investor complaints as per Regulation 13(3) of SEBI (LODR) Regulations, 2015 for the quarter ended 31st March, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Prism Medico and Pharmacy Ltd has submitted its quarterly investor complaints report to BSE and MSE under SEBI Regulation 13(3) for the quarter ended 31 March 2025. The report, also confirmed by the company's Registrar Purva Sharegistry (India) Pvt Ltd, shows zero complaints pending at the start of the quarter. No new complaints were received during the quarter, none were disposed of, and none remained unresolved at the end. This is a routine regulatory compliance filing required of all listed companies each quarter.
No impact on shareholders or stock price — this is a standard quarterly compliance disclosure indicating a clean investor grievance record with no pending complaints.